Scholars@Duke

Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration.

Publication ,  Journal Article
Puthumana, J; Egilman, AC; Zhang, AD; Schwartz, JL; Ross, JS
Published in: JAMA internal medicine
April 2021
Published version (DOI)

Duke Scholars

Audrey Zhang
Author Audrey Zhang  
Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA internal medicine

DOI

10.1001/jamainternmed.2020.7472

EISSN

2168-6114

ISSN

2168-6106

Publication Date

April 2021

Volume

181

Issue

4

Start / End Page

559 / 560

Related Subject Headings

  • Vaccines
  • Vaccine Development
  • United States Food and Drug Administration
  • United States
  • Humans
  • Drug Approval
  • 4203 Health services and systems
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1113 Opthalmology and Optometry
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Puthumana, J., Egilman, A. C., Zhang, A. D., Schwartz, J. L., & Ross, J. S. (2021). Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration. JAMA Internal Medicine, 181(4), 559–560. https://doi.org/10.1001/jamainternmed.2020.7472
Puthumana, Jeremy, Alexander C. Egilman, Audrey D. Zhang, Jason L. Schwartz, and Joseph S. Ross. “Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration.” JAMA Internal Medicine 181, no. 4 (April 2021): 559–60. https://doi.org/10.1001/jamainternmed.2020.7472.
Puthumana J, Egilman AC, Zhang AD, Schwartz JL, Ross JS. Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration. JAMA internal medicine. 2021 Apr;181(4):559–60.
Puthumana, Jeremy, et al. “Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration.” JAMA Internal Medicine, vol. 181, no. 4, Apr. 2021, pp. 559–60. Epmc, doi:10.1001/jamainternmed.2020.7472.
Puthumana J, Egilman AC, Zhang AD, Schwartz JL, Ross JS. Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration. JAMA internal medicine. 2021 Apr;181(4):559–560.

Published In

JAMA internal medicine

DOI

10.1001/jamainternmed.2020.7472

EISSN

2168-6114

ISSN

2168-6106

Publication Date

April 2021

Volume

181

Issue

4

Start / End Page

559 / 560

Related Subject Headings

  • Vaccines
  • Vaccine Development
  • United States Food and Drug Administration
  • United States
  • Humans
  • Drug Approval
  • 4203 Health services and systems
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1113 Opthalmology and Optometry